公司概覽
業務類別 Biotechnology
業務概覽 AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
公司地址 EPFL Innovation Park, Building B, Lausanne, CHE, 1015
電話號碼 +41 213459121
傳真號碼 +41 213459120
公司網頁 https://www.acimmune.com
員工數量 161
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Christopher Roberts Chief Financial Officer -- 13/03/2025
Mr. Mark Danton Executive Vice President, Information Systems and Artificial Intelligence -- 13/03/2025
Dr. Francesca Capotosti, PhD Vice President, Research -- 13/03/2025
Dr. Matthias Maurer, PhD Senior Vice President and General Counsel -- 13/03/2025
Professor Dr. Andrea Pfeifer, PhD Chief Executive Officer and Director -- 13/03/2025
Dr. Olivier Sol, M.D. Vice President and Head of Clinical Development -- 13/03/2025
Mr. Piergiorgio Donati Chief Technical Operations Officer -- 13/03/2025
Mr. Howard Donovan Chief Human Resources Officer -- 13/03/2025
Dr. Julien Rongere, PhD Senior Vice President, Regulatory Affairs and Quality Assurance -- 13/03/2025
Dr. Bojana Portmann, PhD Vice President, IP and Business Development -- 13/03/2025
Dr. Gunther Staffler, PhD Senior Vice President, Immunotherapy -- 13/03/2025
Dr. Anke Post, M.D. Chief Medical Officer -- 13/03/2025
Dr. Gary Waanders, PhD Senior Vice President, Investor Relations and Corporate Communications -- 13/03/2025
 
董事會成員
董事會 職務 更新日期
Dr. Douglas E. Williams,PhD Chairman of the Board 13/03/2025
Dr. Werner Lanthaler, PhD Independent Director 13/03/2025
Professor Dr. Monika Butler, PhD Vice Chairman of the Board 13/03/2025
Professor Dr. Andrea Pfeifer, PhD Chief Executive Officer and Director 13/03/2025
Dr. Roy Twyman, M.D. Independent Director 13/03/2025
Professor Dr. Carl June, M.D. Independent Director 13/03/2025
Dr. Monica Shaw, M.D. Independent Director 13/03/2025
 
所屬ETF (更新日期: 07/03/2026 03:44)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.46%28/02/2026
DFASDimensional US Small Cap ETF0.06%27/02/2026
DFAUDimensional US Core Equity Market ETF0.01%27/02/2026
DFACDimensional US Core Equity 2 ETF0.01%27/02/2026
DCORDimensional US Core Equity 1 ETF0.01%27/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
DXUVDimensional US Vector Equity ETF0.003%27/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.003%27/02/2026
BMEDiShares Health Innovation Active ETF<0.000001%26/02/2026
BMEZBlackRock Health Sciences Term Trust<0.000001%31/12/2025
DFATDimensional US Targeted Value ETF<0.000001%17/09/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.